ARTICLE | Clinical News
Pfizer preclinical data
July 26, 2010 7:00 AM UTC
In mouse models of hemophilia, Pfizer's second-generation recombinant activated Factor VIIa molecule produced more potent restoration of hemostasis compared to native Factor VII. Data were presented a...